Virginia Tech’s Carilion School of Medicine Has Put a Special Focus on Rare Disease

Currently, 95% of rare diseases don't have an effective treatment. Progress is being made, but there is just so much ground to cover in rare disease research. Studying rare diseases…

Continue Reading Virginia Tech’s Carilion School of Medicine Has Put a Special Focus on Rare Disease
ARCT-810 Dosing Begun in Phase 1b Trial for OTC Deficiency
Arcaion / Pixabay

ARCT-810 Dosing Begun in Phase 1b Trial for OTC Deficiency

In early December 2020, mRNA medicines company Arcturus Therapeutics Holdings Inc. ("Arcturus") announced that the company begun dosing participants within its Phase 1b clinical trial. Within the trial, researchers will…

Continue Reading ARCT-810 Dosing Begun in Phase 1b Trial for OTC Deficiency
Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
source: pixabay.com

Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder

  In an article in Medical Xpress, Japanese doctors have performed a “first” by transplanting liver cells (made with embryonic stem cells) into a newborn. The six-day-old infant was diagnosed with…

Continue Reading Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials
Pixabay

An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

Ornithine transcarbamylase (OTC) deficiency is a disorder that can cause comas, seizures, and death, making it necessary for those affected to seek treatment. Arcturus Therapeutics aims to give those with…

Continue Reading An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials
Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year
source: pixabay.com

Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year

Three non-investigational New Drug clinical studies are underway for Urea Cycle Disorders (UCD) and various forms of cirrhosis, initiated by Kaleido Biosciences. Dosing has been initiated in each of these…

Continue Reading Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year
Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy
NeuPaddy / Pixabay

Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy

According to a story from ctvnews.ca, a recent treatment with gene therapy appears to have changed the life of thirty year old Josh McQuillin, who has a urea cycle disorder,…

Continue Reading Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy
CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency
Source: Pixabay

CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency

Another successful partnership in the rare disease community has come to fruition, reports The Pharma Letter. Just this past week, CureVac and Arcturus Therapeutics will become a powerhouse together with…

Continue Reading CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency
Urea Cycle Disorders: How Deadly Bacteria Could Save Your Life
https://pixabay.com/en/e-coli-hazard-e-coli-warning-skull-1882290/

Urea Cycle Disorders: How Deadly Bacteria Could Save Your Life

G-M-O. Three letters guaranteed to spark lively, if not heated, debate amongst lifelong friends. These three letters, of course, stand for "genetically modified organisms." Why are they so controversial? Why…

Continue Reading Urea Cycle Disorders: How Deadly Bacteria Could Save Your Life